Pathophysiology, Risk factors and Management of Chronic Heart Failure, Volume 2 is the second of two separate but closely related volumes which aim to provide an inclusive overview on Chronic Heart Failure (CHF).This second volume is focused on the therapies of various kinds, management, guidelines and future advances in heart failure. It explains the uncertainties and issues in pharmacological therapies in CHF, along with a number of new treatment options such as gene therapy, cell implantation therapy, invasive and surgical interventions, and non-pharmacological therapies, which would include dietary interventions, holistic approaches, and physical training. It discusses in depth the management of patients with heart failure, and concludes with detailed and updated guidelines from the International College of Cardiology, as well as future research directions and advances.These 2 separate volumes serve as essential references to both researchers and practicing clinicians, proposing novel methods of research by using behavioural and environmental risk factors as intervention agent, as well as discussing deficiency in the present approaches in management of HF and proposing new methods of early diagnosis and therapies for the clinical management of CHF.
